Abstract:In this paper, QSPR models were developed for in vivo blood-brain partitioning data (logBB) of a large data set consisting of 115 diverse organic compounds. The best model is based on three descriptors: n-octanol/water partition coefficient calculated using the SLOGP approach, logP; high-charged polar surface areas based on the Gasteiger partial charges, HCPSA, and the excessive molecular weight larger than 360, MW(360). The model bears good statistical significance, n = 78, r = 0.88, q = 0.86, s = 0.36, F = 81.5. The actual prediction potential of the model was validated through two external validation sets of 37 diverse compounds. The predicted results demonstrate that the model bears better prediction potential than many other models and can be used for logBB estimations for drug and drug-like molecules. Comparison of several logP calculation approaches suggests that logP calculated by SLOGP can be used as a significant descriptor for the prediction of molecular transport properties because SLOGP gives the most similar results with CLOGP. The QSPR model indicates that larger polar surface areas have a more negative contribution to logBB, but the absolute partial charges on the atoms surrounded by the polar surfaces should be larger than 0.10|e|. Meanwhile, tight junction membranes limit the size of hydrophilic molecules that can cross the membrane with a molecular weight of approximately 360, because when a molecule's weight is larger than 360 it shows a negative contribution to logBB. The computations of molecular surface, partial charges, logP, and logBB have been accomplished using a program called Drug-BB. Moreover, to improve the efficiency of the computations of logP, we made an extensive reparametrization of SLOGP, and the newly developed SLOGP model is only based on simple atomic addition. Further, we developed a set of parameters to calculate the topological polar surface area (TPSA), thus the high-charged topological polar surface area (HCTPSA) could be estimated from the 2D connection information of a molecule. Adopting the new strategies, the estimations of logP, HCTPSA, and logBB are only based on the topological structure of a molecule and therefore, can be used for fast screening of virtual libraries having millions of molecules.

ADME evaluation in drug discovery. 1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs.

1. Applications of Genetic Algorithms to the Prediction of Blood-Brain Partitioning of a Large Set of Drugs

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

In Silico Prediction of Blood–Brain Partitioning Using a Chemometric Method Called Genetic Algorithm Based Variable Selection

ADME Properties Evaluation in Drug Discovery: in Silico Prediction of Blood–brain Partitioning

Adme Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors

ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors [J. Chem. Inf. Comput. Sci. 43, 2137-2152 (2003)]

ADME Properties Evaluation in Drug Discovery: Prediction of Caco-2 Cell Permeability Using a Combination of NSGA-II and Boosting

ADME Properties Evaluation in Drug Discovery: Prediction of Plasma Protein Binding Using NSGA-II Combining PLS and Consensus Modeling

ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques.

Estimation of ADME Properties with Substructure Pattern Recognition

Comparison of Descriptor- and Fingerprint Sets in Machine Learning Models for ADME-Tox Targets

Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.

In Silico Prediction of Blood-Brain Barrier Permeability of Compounds by Machine Learning and Resampling Methods.

ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints.

In Silico ADME Modeling 3: Computational Models to Predict Human Intestinal Absorption Using Sphere Exclusion and kNN QSAR Methods

Development of QSAR models to predict blood-brain barrier permeability

Prediction of Blood-Brain Barrier Permeability of Compounds by Fusing Resampling Strategies and eXtreme Gradient Boosting

Quantitative structure/activity relationship modelling of pharmacokinetic properties using genetic algorithm-combined partial least squares method

Prediction of Blood–brain Partitioning: A Model Based on Molecular Electronegativity Distance Vector Descriptors

A Predictive Model for Blood-Brain Barrier Penetration